Avera McKennan Hospital & University Health Center
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Avera McKennan Hospital & University Health Center sits in the top decile of US sponsors by registered trial count (#743 of 15,742 sponsors by registered trial count).
Avera McKennan Hospital & University Health Center: 20 sponsored US clinical trials, 1 recruiting.
Avera McKennan Hospital & University Health Center sponsors 20 registered US clinical trials on ClinicalTrials.gov, 1 of them currently recruiting, and 17 completed. 0 of these trials are in Phase 3-4 (later-stage) and 4 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Breast Cancer, with 2 trials.
Top-decile sponsor footprint
Avera McKennan Hospital & University Health Center ranks in the top decile of sponsors by registered trial count (#743 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
17 of 18 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (94.4%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
20 total, page 1 of 1
Avera Cancer Sequencing and Analytics Protocol (ASAP)
NCT05142033
Node Negative, Invasive Breast Cancer Single Fraction IOERT
NCT02370797
Infant Care Practices Study
NCT03494621
Evaluation of the Safety and Tolerability of Niraparib With Everolimus in Advanced Gynecologic Malignancies and Breast
NCT03154281
Evaluation of the Safety and Tolerability of TAK-228 With TAK-117 and Paclitaxel in Advanced Solid Tumors
NCT03154294
A Study of Protein Metabolism, Microbiome and Investigational Probiotic Use in Patients With ALS
NCT03324399
Evaluation of Pharmacogenetic Testing In a Mental Health Population and Economic Outcomes
NCT02474680
Pharmacogenetic Testing on an Outpatient Population With a Depression Diagnosis
NCT02443584
Pharmacogenetic Testing in an Outpatient Population of Patients With Depression
NCT02497027
Use of Metformin to Reduce Cardiac Toxicity in Breast Cancer
NCT02472353
Identifying Molecular Drivers of Cancer
NCT02470715
Pharmacogenomics and Effective Treatment With Clopidogrel
NCT01611545
Evaluate the Change in Iron, Vitamin D, and C-Reactive Protein Level (CRP) in a 12 to 24 Week Period
NCT01328704
Randomized Study to Evaluate the Effect of an Investigational Product on Weight Loss and Body Composition
NCT01272739
The Occurrence of the ApoE4 Allele in Agitated In-Patients With Late-Onset Alzheimer's Disease
NCT01329536
Effects of Music Intervention on the Brain Development of Preschool Children
NCT01275001
A Study to Compare Genetic Variations of IGF-I and IGF-II
NCT01329523
A Study to Evaluate Glucose and Insulin Response to Nutralin
NCT01275820
A Study of Vitamin D in Subjects With Alopecia Areata
NCT01328678
Influence of Education on Acceptance of Treatment for Attention Deficit Hyperactivity Disorder (ADHD) Among Women
NCT01272726
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 2 |
| Phase 2 | 2 |
Therapeutic Areas
What is open in the Avera McKennan Hospital & University Health Center pipeline
1 recruiting of 20 indexed (5% open); 17 completed (85%).
Phase mix: 0 late (III/IV) vs 4 early (I/II) (early-phase heavy).
Top condition: Breast Cancer (2 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Avera McKennan Hospital & University Health Center: open-pipeline peers nationwide
Peers matched on 20 registered trials and 5% open enrollment, not the therapeutic-area sidebar.
Avera McKennan Hospital & University Health Center sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 20 trials (± recruiting share)
- 59th Medical Wing · 20 trials · 15% recruiting
- Abiomed · 20 trials · 10% recruiting
- Agency for Healthcare Research and Quality (AHRQ) · 20 trials · 0% recruiting
- Alliance Foundation Trials · 20 trials · 15% recruiting
Sponsors near 5% open enrollment (± trial volume)
- HonorHealth Research Institute · 5% recruiting · 20 trials
- Integra LifeSciences Corporation · 5% recruiting · 60 trials
- Lumenis Be · 5% recruiting · 20 trials
- Nathan Kline Institute for Psychiatric Research · 5% recruiting · 20 trials
Related
What to do with this Avera McKennan Hospital & University Health Center page
20 registered trials is a research-attention snapshot, not an endorsement of Avera McKennan Hospital & University Health Center or any single study.
- 1 of Avera McKennan Hospital & University Health Center's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Breast Cancer is the condition Avera McKennan Hospital & University Health Center studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Breast Cancer trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Avera McKennan Hospital & University Health Center pipeline card: 20 registered trials from official public datasets.Report a data error.